1 – 10 of 116
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLC
(2025) In Journal of Thoracic Oncology
- Contribution to journal › Article
-
Mark
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
Taş, İsa LU ; Jacobs, Ruben LU ; Albrecht, Juliane LU
; Barrientos, Sebastian A
LU
; Åberg, Josephine
LU
; Sime, Wondossen
LU
; Brunnström, Hans
LU
; Persson, Helena
LU
; Kazi, Julhash U
LU
and Massoumi, Ramin
LU
(2025)
In Journal of Experimental and Clinical Cancer Research
44.
- Contribution to journal › Article
-
Mark
Localization, Proteolytic Processing, and Binding Partners of Versican Isoforms in Vascular Lesions of Pulmonary Arterial Hypertension
Westöö, Christian LU ; Mutgan, Ayse Ceren LU
; van der Have, Oscar
LU
; Mead, Timothy J
; Ahmed, Salaheldin
LU
; Lampei, Elna
LU
; Koch, Christopher D
; Norvik, Christian
LU
; Aspberg, Anders
LU
and Bech, Martin
LU
, et al.
(2025)
In The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
- Contribution to journal › Article
- 2024
-
Mark
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
Enokido, Takayoshi ; Horie, Masafumi ; Yoshino, Seiko ; Suzuki, Hiroshi I. ; Matsuki, Rei ; Brunnstrom, Hans LU
; Micke, Patrick
; Nagase, Takahide
; Saito, Akira
and Miyashita, Naoya
(2024)
In Molecular Cancer Research
22(1).
p.29-40
- Contribution to journal › Article
-
Mark
First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden : A Population-based Real-world Study with Focus on Immunotherapy
Wagenius, Gunnar ; Vikström, Anders ; Berglund, Anders ; Salomonsson, Stina ; Bencina, Goran ; Hu, Xiaohan ; Chirovsky, Dana and Brunnström, Hans LU
(2024)
In Acta oncologica (Stockholm, Sweden)
63.
p.198-205
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
Malmros, Karina LU ; Lindholm, Andreas ; Vidarsdottir, Halla LU ; Jirström, Karin LU
; Nodin, Björn
LU
; Botling, Johan
; Mattsson, Johanna S.M.
; Micke, Patrick
; Planck, Maria
LU
and Jönsson, Mats
LU
, et al.
(2024)
In Virchows Archiv
485.
p.347-357
- Contribution to journal › Article
-
Mark
The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks
Mansour, Mohammed S I LU
; Pettersson, Louise
LU
; Seidal, Tomas
; Strömberg, Ulf
; Mager, Ulrich
; Ali, Lana
; Kumbaric, Sana
; Hejny, Kim
; Taheri-Eilagh, Fereshteh
and Mufti, Joudy
, et al.
(2024)
In Cancer Cytopathology
132(9).
p.569-579
- Contribution to journal › Article
-
Mark
3D cultivation of non-small-cell lung cancer cell lines using four different methods
Malmros, Karina LU ; Kirova, Nadi LU ; Kotarsky, Heike LU ; Carlsén, Daniel ; Mansour, Mohammed S I LU
; Magnusson, Mattias
LU
; Prabhala, Pavan
LU
and Brunnström, Hans
LU
(2024)
In Journal of Cancer Research and Clinical Oncology
150.
p.1-10
- Contribution to journal › Article
-
Mark
Overlapping Systemic Proteins in COVID-19 and Lung Fibrosis Associated with Tissue Remodeling and Inflammation
Svobodová, Barbora LU ; Löfdahl, Anna LU ; Nybom, Annika LU ; Wigén, Jenny LU ; Hirdman, Gabriel LU ; Olm, Franziska LU
; Brunnström, Hans
LU
; Lindstedt, Sandra
LU
; Westergren-Thorsson, Gunilla
LU
and Elowsson, Linda
LU
(2024)
In Biomedicines
12(12).
- Contribution to journal › Article
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
Nobin, Hampus LU ; Garvin, Stina ; Hagman, Helga LU
; Nodin, Björn
LU
; Jirström, Karin
LU
and Brunnström, Hans
LU
(2024)
In BMC Cancer
24.
p.1-16
- Contribution to journal › Article